Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Inspire Medical Systems Inc (NYSE: INSP) closed at $90.06 up 1.95% from its previous closing price of $88.34. In other words, the price has increased by $1.95 from its previous closing price. On the day, 0.96 million shares were traded. INSP stock price reached its highest trading level at $91.37 during the session, while it also had its lowest trading level at $87.94.
Ratios:
For a deeper understanding of Inspire Medical Systems Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.33. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 6.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
JP Morgan Downgraded its Overweight to Neutral on August 05, 2025, while the target price for the stock was maintained at $110.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 19 ’25 when Rondoni John sold 1,734 shares for $149.38 per share. The transaction valued at 259,025 led to the insider holds 13,766 shares of the business.
JOHN RONDONI bought 1,734 shares of INSP for $259,025 on May 19 ’25. On May 02 ’25, another insider, mcCormick Shawn, who serves as the Director of the company, sold 360 shares for $160.00 each. As a result, the insider received 57,600 and left with 24,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 2663461376 and an Enterprise Value of 2395627008. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 52.17, and their Forward P/E ratio for the next fiscal year is 60.69. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.09 while its Price-to-Book (P/B) ratio in mrq is 3.93. Its current Enterprise Value per Revenue stands at 2.781 whereas that against EBITDA is 45.905.
Stock Price History:
The Beta on a monthly basis for INSP is 1.15, which has changed by -0.5192441 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $225.00, while it has fallen to a 52-week low of $73.92. The 50-Day Moving Average of the stock is -24.96%, while the 200-Day Moving Average is calculated to be -43.79%.
Shares Statistics:
For the past three months, INSP has traded an average of 893.35K shares per day and 1538590 over the past ten days. A total of 29.57M shares are outstanding, with a floating share count of 26.72M. Insiders hold about 9.65% of the company’s shares, while institutions hold 106.25% stake in the company. Shares short for INSP as of 1753920000 were 2511665 with a Short Ratio of 2.81, compared to 1751241600 on 3285458. Therefore, it implies a Short% of Shares Outstanding of 2511665 and a Short% of Float of 11.399999.
Earnings Estimates
Inspire Medical Systems Inc (INSP) is presently subject to a detailed evaluation by 13.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.67, with high estimates of $0.84 and low estimates of $0.55.
Analysts are recommending an EPS of between $1.64 and $0.4 for the fiscal current year, implying an average EPS of $0.86. EPS for the following year is $1.51, with 14.0 analysts recommending between $2.25 and $1.11.
Revenue Estimates
A total of 16 analysts believe the company’s revenue will be $221.38M this quarter.It ranges from a high estimate of $224.9M to a low estimate of $220M. As of the current estimate, Inspire Medical Systems Inc’s year-ago sales were $203.19MFor the next quarter, 16 analysts are estimating revenue of $264.66M. There is a high estimate of $266.7M for the next quarter, whereas the lowest estimate is $261.4M.
A total of 17 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $907.9M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $904.47M. In the same quarter a year ago, actual revenue was $802.8MBased on 17 analysts’ estimates, the company’s revenue will be $1.03B in the next fiscal year. The high estimate is $1.06B and the low estimate is $1.01B.
